Clusterin

Clusterin Overview

English NameClusterinApproved Drugs0
Drugs in Clinical Trials1Target SynonymEpididymis Secretory Sperm Binding Protein,CLI,Apolipoprotein J,ApoJbeta,Complement cytolysis inhibitor a chain,Testosterone-repressed prostate message 2,Complement cytolysis inhibitor b chain,ApoJalpha,AAG4,Complement cytolysis inhibitor,NA1/NA2,APOJ,CLU,Clusterin,Complement-Associated Protein SP-40,40,Complement Lysis Inhibitor,Sulfated Glycoprotein 2,Ku70-Binding Protein 1,TRPM-2,KUB1,Clusterin (Complement Lysis Inhibitor, SP-40,40, Sulfated Glycoprotein 2, Testosterone-Repressed Prostate Message 2, Apolipoprotein J),Aging-Associated Gene 4 Protein,Aging-Associated Protein 4,APO-J,SGP-2,SP-40,CLU1,CLU2,SGP2,TRPM2
Highest Development StagePhase 2 Clinical
English NameClusterin
Target SynonymEpididymis Secretory Sperm Binding Protein,CLI,Apolipoprotein J,ApoJbeta,Complement cytolysis inhibitor a chain,Testosterone-repressed prostate message 2,Complement cytolysis inhibitor b chain,ApoJalpha,AAG4,Complement cytolysis inhibitor,NA1/NA2,APOJ,CLU,Clusterin,Complement-Associated Protein SP-40,40,Complement Lysis Inhibitor,Sulfated Glycoprotein 2,Ku70-Binding Protein 1,TRPM-2,KUB1,Clusterin (Complement Lysis Inhibitor, SP-40,40, Sulfated Glycoprotein 2, Testosterone-Repressed Prostate Message 2, Apolipoprotein J),Aging-Associated Gene 4 Protein,Aging-Associated Protein 4,APO-J,SGP-2,SP-40,CLU1,CLU2,SGP2,TRPM2
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 2 Clinical

Clusterin Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
CLU-H5227
Human
HEK293
Human Clusterin / CLUS Protein, His Tag
Total: 1
  • 1

Clusterin Background

Clusterin (CLU) is also known as dimeric acidic glycoprotein (DAG protein), testosterone repressed prostate message-2 (TRPM-2), sulfated glycoprotein-2 (SGP-2) and complement lysis inhibitor (CLI), is a secreted multifunctional glycoprotein protein which belongs to the clusterin family. Intracellular cleavages of the precursor of clusterin remove the signal peptide and generate comparably sized α and β chains which are secreted as an 80 kDa N­glycosylated disulfide­linked heterodimer. DAG protein is predominantly expressed in adult testis, ovary, adrenal gland, liver, heart, and brain and in many epithelial tissues during embryonic development. Clusterin involve in several basic biological events such as cell death, tumor progression, and neurodegenerative disorders. Upregulation of clusterin mRNA and protein levels detected in diverse disease states and in in vitro systems have led to suggestions that it functions in membrane lipid recycling, in apoptotic cell death, and as a stress-induced secreted chaperone protein, amongst others.

Clusterin Synonyms

CLU,Clusterin,AAG4,APOJ,CLI,KUB1,SGP-2,SP-40,TRPM2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SotevtamabAB-sCLU mAB; 16B5; AB-16B5Phase 2 ClinicalNational Research Council Biotechnology Research InstituteCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasm Metastasis; Solid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8